Dong Kim

Insider Reports History

Entity
Individual
Location
C/O Urogen Pharma, Ltd., 400 Alexander Park Drive, 4 Th Floor, Princeton, NJ
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dong Kim:

Stock Role Class Num Shares Value Price $ Report Date Ownership
UroGen Pharma Ltd. Chief Financial Officer Ordinary Shares 37.8K $494K $13.08 Sep 9, 2024 Direct
UroGen Pharma Ltd. Chief Financial Officer Stock Option (right to buy) 20K Mar 25, 2022 Direct
UroGen Pharma Ltd. Chief Financial Officer Restricted Stock Units 5K Sep 9, 2024 Direct

Insider Reports Filed by Dong Kim

Symbol Company Period Transactions Value $ Form Type Date Filed Role
URGN UroGen Pharma Ltd. Sep 9, 2024 2 $0 4 Sep 12, 2024 Chief Financial Officer
URGN UroGen Pharma Ltd. Jan 31, 2024 1 $0 4/A Feb 12, 2024 Chief Financial Officer
URGN UroGen Pharma Ltd. Jan 31, 2024 3 $0 4 Feb 2, 2024 Chief Financial Officer
URGN UroGen Pharma Ltd. Sep 7, 2023 1 $0 4 Sep 8, 2023 Chief Financial Officer
URGN UroGen Pharma Ltd. Jan 31, 2023 2 $0 4 Feb 2, 2023 Chief Financial Officer
URGN UroGen Pharma Ltd. Mar 25, 2022 1 $0 4/A Feb 12, 2024 Chief Financial Officer
URGN UroGen Pharma Ltd. Mar 25, 2022 1 $0 4 Mar 29, 2022 Chief Financial Officer
URGN UroGen Pharma Ltd. Mar 25, 2022 0 $0 3 Mar 29, 2022 Chief Financial Officer